These findings suggested that the SLC22A3 rs539298A allele may be a genetic risk factor for ischaemic cardiovascular and cerebrovascular diseases, and the SLC22A3 rs539298G allele may reduce the risk of CAD and IS by affecting serum TC levels. This evidence concerns the gene SLC22A3 and cerebrovascular disorder.